ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1607

The Impact of Health Literacy and Numeracy on COVID-19 Vaccine Hesitancy in SLE

Rebecca Sadun1, Mithu Maheswaranathan1, Megan Clowse2, Kai Sun1, Jennifer Rogers1, Jayanth Doss1, Lisa Criscione-Schreiber3 and Amanda Eudy1, 1Duke University, Durham, NC, 2Duke University, Chapel Hill, NC, 3Duke University School of Medicine, Durham, NC

Meeting: ACR Convergence 2021

Keywords: COVID-19, Literacy, socioeconomic factors, Systemic lupus erythematosus (SLE), Vaccination

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster IV: COVID-19 (1589–1613)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: The ACR has issued guidance recommending COVID-19 vaccine for all patients with rheumatic diseases. Vaccine hesitancy research prior to the COVID-19 pandemic has demonstrated associations between health literacy and vaccine hesitancy. In this study, we assessed the relationship between SLE patients’ desire to receive a COVID-19 vaccine and their health literacy/numeracy.

Methods: Health literacy was assessed by the Newest Vital Sign (NVS); NVS < 4 denotes limited health literacy. Numeracy was assessed with the Subjective Numeracy Scale (SNS-3); SNS-3 ≤12 was considered to be low numeracy. The Vaccine Hesitancy Scale (VHS) was modified to assess adult vaccine beliefs, with additional questions specific to the COVID-19 vaccine and patients’ self-assessed COVID-19 risk. The survey also asked whether patients would choose to get the COVID-19 vaccine if it were made available to them the following week (definitely/probably vs probably not/definitely not). The survey was distributed by email on 02/24/2021 to the 353 patients in the Duke Lupus Registry, all of whom met ACR or SLICC criteria for SLE. Linear regression models adjusted for education estimated the associations of health literacy and numeracy on the desire to receive the COVID-19 vaccine.

Results: A total of 63 patients who completed the COVID-19 vaccine had recently completed an assessment of health literacy or numeracy: 38 patients had completed the NVS, 57 had completed the SNS-3, and 32 had completed both. Overall, 98% of respondents were female, 56% White, and 68% college educated (Table 1). Patients with adequate health literacy were more likely to be college educated (p=0.04), and patients with limited health literacy were more likely to lack private health insurance (p=0.03); these associations were not seen for numeracy.

Importantly, 60 out of 63 SLE patients (95%) wanted to receive the COVID-19 vaccine as soon as possible. Adequate and limited literacy patients had similar VHS scores and were similar on most sub-scales, although there was a trend toward more hesitancy in the low literacy group for the Safety sub-scale (Table 2). Within this sub-scale, even after adjusting for education, limited literacy patients were more likely to express fear of vaccines causing autism (p=0.05), fear of getting COVID-19 from the vaccine (p=0.05), and fear that the COVID-19 vaccine was rushed (p=0.05). Limited numeracy patients were less likely to agree with having a family member who is high-risk for COVID-19, although their assessment of personal risk for severe COVID-19 was similar to adequate numeracy patients (Table 3).

Conclusion: The vast majority of SLE respondents wanted to receive the vaccine, regardless of health literacy and numeracy status. Patients with limited health literacy were more likely to believe vaccine falsehoods, including concerned that vaccines cause autism, that they could get COVID-19 from the vaccine, and that the COVID-19 vaccine was rushed; such patients may be more susceptible to vaccine conspiracy theories.

Table 1. Study population.

Table 2. Associations between literacy and vaccine beliefs.

Table 3. Associations between numeracy and vaccine beliefs.


Disclosures: R. Sadun, None; M. Maheswaranathan, None; M. Clowse, UCB Pharma, 2, Pfizer, 5, GSK, 2, 5; K. Sun, None; J. Rogers, Exagen, 2, 5, Pfizer, 5, Eli Lilly, 2, Immunovant, 2, Northwestern University, 2; J. Doss, Pfizer, 5; L. Criscione-Schreiber, GlaxoSmithKline, 5; A. Eudy, NIH NCATS Award Number 1KL2TR002554, 5, Pfizer, 5, Exagen, 5.

To cite this abstract in AMA style:

Sadun R, Maheswaranathan M, Clowse M, Sun K, Rogers J, Doss J, Criscione-Schreiber L, Eudy A. The Impact of Health Literacy and Numeracy on COVID-19 Vaccine Hesitancy in SLE [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-health-literacy-and-numeracy-on-covid-19-vaccine-hesitancy-in-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-health-literacy-and-numeracy-on-covid-19-vaccine-hesitancy-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology